Article

Identification of STAT5A as drug screening biomarker and immune checkpoint inhibitor in stomach adenocarcinoma via comprehensive bioinformatics analysis

2020-04-30

Abstract excerpt

<h4>Background: </h4> Gastric cancer is one of the fatal diseases and the third leading cause of cancer-related deaths worldwide. Limited drugs or therapeutic methods could be applied for these patients, and their prognosis was poor median overall survival (OS) of about 10 months. Increasing evidences demonstrated STAT gene family as biomarkers for prognosis, immunotherapy and drug screening. <h4>Methods: </h4>: T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3cc21b2f-e982-5105-9f20-3d6212dbf14a
DOI: 10.21203/rs.3.rs-24062/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of STAT5A as drug screening biomarker and immune checkpoint inhibitor in stomach adenocarcinoma via comprehensive bioinformatics analysisDOI 10.21203/rs.3.rs-24062/v1Read

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survivalSemantic proximity Read

Identification of Prognosis Signature and Analysis of the Immune Microenvironment in Gastric Cancer Based on ALKBH5Semantic proximity Read

The Histone Acetylation-Related Gene Signature for Prediction of Prognosis and Immunotherapy Efficacy in Stomach Adenocarcinoma and Verification in vitroSemantic proximity Read

Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.Semantic proximity Read

N 6 -methyladenosine (m 6 A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint moleculesSemantic proximity Read

WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinomaSemantic proximity Read

Prognostic values of signal transducers activators of transcription in gastric cancerSemantic proximity Read

FASTKD1 is a diagnostic and prognostic biomarker for STAD associated with m6A modification and immune infiltrationSemantic proximity Read

Complement system-related genes in stomach adenocarcinoma: Prognostic signature, immune landscape, and drug resistanceSemantic proximity Read

Comprehensive Analysis of the Prognostic Value of ITGB Superfamily Members in Gastric Cancer Using Bioinformatics AnalysisSemantic proximity Read

STAT5A modulates gastric cancer progression via upregulation of CD44Semantic proximity Read